Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quantum-Si Inc (NQ: QSI )

0.8355 -0.0045 (-0.54%)
Streaming Delayed Price Updated: 2:46 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 253,033
Open 0.8355
Bid (Size) 0.8355 (2)
Ask (Size) 0.8399 (15)
Prev. Close 0.8400
Today's Range 0.8355 - 0.8700
52wk Range 0.7320 - 2.430
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing
From Quantum-Si Incorporated
Via Business Wire

Performance

YTD
-58.84%
-58.84%
1 Month
-7.17%
-7.17%
3 Month
-12.25%
-12.25%
6 Month
-53.58%
-53.58%
1 Year
-46.78%
-46.78%

More News

Read More
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
From Quantum-Si Incorporated
Via Business Wire
Recap: Quantum-Si Q4 Earnings
Via Benzinga
Liberate Bio Integrates Quantum-Si’s Next-Generation Protein Sequencing™ Platform to Enhance Gene Therapy Development
From Quantum-Si Incorporated
Via Business Wire
CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Reports Second Quarter 2024 Financial Results
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024
From Quantum-Si Incorporated
Via Business Wire
3 Super-Cheap Penny Stocks for the Ultimate Speculator
Via InvestorPlace
Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Announces Presentations at ASMS and ESHG
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors
From Quantum-Si Incorporated
Via Business Wire
QSI Stock Earnings: Quantum-Si Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Quantum-Si Reports First Quarter 2024 Financial Results
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
From Quantum-Si Incorporated
Via Business Wire
Penny Stock Quantum-Si Incorporated Readies For Lift-Off
Via MarketBeat
3 Cheap Stocks that Insiders Bought in Q1
Via MarketBeat
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference
From Quantum-Si Incorporated
Via Business Wire
Quantum-Si And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
From Quantum-Si Incorporated
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.